Myeloid cell-specific DCLK1 deletion or pharmacological inhibition of DCLK1 reduced cardiac hypertrophy and fibrosis, thereafter, restored heart function in HFD-fed mice. Here, DCLK1 is linked to cardiac hypertrophy.